Hypertonic Saline: Uses, Benefits, Risks, and How It Works

Hypertonic saline is a saltwater solution with a sodium chloride concentration greater than normal saline. In respiratory care, it is most often used as an inhaled aerosol to help mobilize airway secretions, stimulate coughing, and obtain sputum specimens for diagnostic testing.

It is also used as part of airway clearance therapy for certain conditions, especially cystic fibrosis and sometimes bronchiectasis.

Although it is considered a relatively simple therapy, hypertonic saline has important clinical effects because it changes water movement at the airway surface and may trigger bronchospasm in sensitive patients.

What Is Hypertonic Saline?

Hypertonic saline is a saline solution with a higher osmotic pressure than normal body fluids. Normal saline is 0.9% sodium chloride and is considered approximately isotonic because its osmotic pressure is similar to that of body fluids. Any saline solution with a sodium chloride concentration greater than 0.9% is considered hypertonic.

In respiratory care, hypertonic saline is commonly delivered as an aerosol through a nebulizer. The most commonly discussed concentrations include 3%, 5%, 7%, and 10%, although some references include concentrations as low as 1.8%. Hypertonic saline is different from normal saline because it has a stronger osmotic effect on airway tissues and secretions.

The word hypertonic refers to the ability of a solution to draw water toward itself. When hypertonic saline reaches the airway surface, it pulls water into the airway mucus layer. This can increase the volume of airway surface liquid, make secretions more watery, and help the patient cough mucus out of the lungs.

Hypertonic saline is not a bronchodilator, steroid, antibiotic, or traditional mucolytic drug. It does not directly relax airway smooth muscle, reduce inflammation, kill microorganisms, or chemically break mucus apart. Instead, it works mainly by hydration, irritation, and stimulation of cough. For this reason, it is often grouped with bland aerosols or mucoactive therapies.

Basic Osmotic Principle

To understand hypertonic saline, it helps to understand osmotic pressure. Water tends to move across membranes toward the area with a higher concentration of dissolved particles. A solution with a high concentration of dissolved particles has greater osmotic pressure and can draw water toward itself.

An isotonic solution has an osmotic pressure similar to body fluids. Normal saline, or 0.9% sodium chloride, is the common example. A hypotonic solution has lower osmotic pressure than body fluids, while a hypertonic solution has higher osmotic pressure.

When a hypertonic solution comes into contact with cells, it tends to draw water out of the cells. In the airway, aerosolized hypertonic saline uses this same principle. After the aerosol particles deposit on the airway surface, the solution draws water into the airway surface liquid and mucus layer. This increases fluid in the sol-gel layer that lines the respiratory tract.

This added water can help loosen secretions and promote their movement. The increased airway surface liquid may improve mucociliary clearance, which is the process by which cilia move mucus upward and out of the respiratory tract. The hypertonic solution can also irritate airway epithelial cells, which helps stimulate cough.

Hypertonic Saline as a Bland Aerosol

In respiratory care, bland aerosol therapy refers to the delivery of sterile water or saline aerosols to the airways. These aerosols may be hypotonic, isotonic, or hypertonic. They are called bland because they do not have a specific pharmacologic action like bronchodilation or antimicrobial activity.

Hypertonic saline is often included in this category, but it is more irritating than normal saline because it is farther from isotonic. This irritation is part of why it can be useful for sputum induction. The airway irritation stimulates coughing, while the osmotic effect adds water to the airway surface.

Bland aerosols have traditionally been used to help with secretion mobilization. However, it is important to understand their limits. Once mucus has already formed, simply adding water does not always change the mucus gel layer dramatically. Because of this, bland aerosols are often described more accurately as expectorants rather than true mucolytics.

Note: A mucolytic breaks down mucus structure. An expectorant helps promote the removal of secretions, often by increasing secretion volume, stimulating cough, or making coughing more productive. Hypertonic saline fits best in this expectorant or mucoactive category.

How Hypertonic Saline Works in the Airways

The effects of inhaled hypertonic saline begin when aerosol particles are deposited in the airway. The higher salt concentration creates an osmotic gradient that pulls water toward the airway surface. This increases the volume of airway surface liquid and may make secretions easier to move.

The therapy can also stimulate a vagally mediated reflex. This reflex may cause bronchial and submucosal glands to release more watery secretions. As a result, the patient may experience an increase in mucus production and a stronger urge to cough.

The combination of watery secretions and coughing is clinically useful. It helps the patient bring mucus from the lower airways into the mouth, where it can be expectorated. This is especially helpful when a sputum sample is needed for testing or when secretions are thick and difficult to clear.

The amount of sputum produced may depend partly on the osmolarity of the inhaled aerosol. In general, a more hypertonic solution has a stronger osmotic effect, but it may also be more irritating. This is why higher concentrations can be effective but may also increase the risk of bronchospasm or discomfort.

Sputum Induction

One of the most common respiratory care uses of hypertonic saline is sputum induction. Sputum induction is used when a patient cannot produce a sputum sample spontaneously, but clinicians need lower-airway secretions for diagnostic testing.

The patient inhales an aerosolized hypertonic saline solution for a short period, often about 5 to 20 minutes, depending on the protocol. The goal is to stimulate coughing and help the patient expectorate a true sputum specimen. A true sputum sample comes from the lower respiratory tract and contains mucus or cellular material from the airways. Saliva is not acceptable because it mainly represents oral secretions rather than lower-airway secretions.

Sputum induction may be used when clinicians suspect diseases such as tuberculosis, fungal infection, Pneumocystis jirovecii pneumonia, or lung cancer. In these cases, induced sputum may be used for microbiological testing, mycobacterial culture, fungal culture, cytology, or other forms of analysis.

Some protocols use 3%, 5%, 7%, or 10% saline. A 7% solution is commonly discussed, but the exact concentration depends on the facility protocol and patient tolerance. If a lower concentration does not produce a sample, the concentration may be increased. If the patient does not tolerate the hypertonic solution, normal saline or hypotonic saline may be considered instead.

Preparing the Patient for Sputum Induction

Proper preparation improves the chance of collecting a useful sputum specimen. The patient may be instructed to rinse and gargle with water before the procedure. Some protocols also ask the patient to brush their teeth and clean the tongue. The goal is to reduce contamination from saliva, food particles, and oral bacteria.

If tuberculosis is suspected, the procedure may be performed early in the morning before breakfast. This can improve the likelihood of collecting a useful lower-airway specimen. Because sputum induction causes coughing, airborne precautions are important when infectious disease is suspected. The procedure may need to be performed in a negative-pressure room or booth, and staff should use appropriate respiratory protection, such as an N95 respirator.

The respiratory therapist should also obtain the correct specimen container before beginning the procedure. The type of container may depend on the suspected condition and the laboratory test being ordered. Cytology, fungal culture, mycobacterial culture, and acid-fast bacilli testing may have different collection requirements.

Before treatment, the respiratory therapist should explain the procedure to the patient. The patient should understand that the goal is to cough up sputum from the chest, not simply spit saliva into the cup. Clear coaching during the procedure can improve the quality of the specimen.

Procedure and Equipment

Hypertonic saline for sputum induction can be delivered by several types of nebulizers. Ultrasonic nebulizers are often used because they can produce a dense aerosol. A dense aerosol is helpful because it delivers a large amount of mist during a short period. Large-volume nebulizers and small-volume nebulizers may also be used depending on the protocol.

The patient typically inhales the aerosol through a mouthpiece or mask. During the procedure, the therapist encourages the patient to cough and expectorate into a sterile container. Some protocols ask the patient to attempt coughing every few minutes or whenever the urge to cough occurs.

A typical induction period may last 15 to 20 minutes, although some descriptions use shorter 5 to 10 minute treatments. The procedure should not continue indefinitely. It should be stopped if the patient becomes distressed, develops bronchospasm, becomes lightheaded, feels nauseated, or cannot tolerate the treatment.

For microbiological testing, a valved breathing circuit with an expiratory HEPA filter may be used. This helps reduce environmental contamination and protects healthcare workers from aerosolized organisms. This is especially important when tuberculosis or another airborne infection is suspected.

Note: An adequate sputum specimen is often several milliliters in volume. Visible mucus plugs or strands suggest that the specimen came from the lower airway. Thin, watery saliva without mucus is less useful and may be rejected by the laboratory.

Diagnostic Uses of Induced Sputum

Hypertonic saline can help collect sputum for several diagnostic purposes. One important use is evaluation for tuberculosis. If tuberculosis is suspected and the patient cannot produce sputum spontaneously, induction may provide a noninvasive way to obtain material for acid-fast bacilli analysis or mycobacterial culture.

It may also be used when fungal infection is suspected. Hypertonic saline can help obtain a specimen for fungal culture or other testing. In certain patients, induced sputum may also be useful when Pneumocystis jirovecii pneumonia is suspected.

Another use is cytologic evaluation for lung cancer. The induced sputum sample may contain airway cells that can be examined for abnormal or malignant changes. This can sometimes help in the diagnostic process, although it does not replace all other forms of testing.

Note: Hypertonic saline should not be used for routine bacterial culture collection. High salt concentrations can inhibit the growth of many bacteria, which may interfere with culture results. This means hypertonic saline may be appropriate for fungal, mycobacterial, or cytology-related sputum induction, but it is not preferred for general bacterial culture.

Safety Concerns and Bronchospasm

The main safety concern with aerosolized hypertonic saline is bronchospasm. Hypertonic aerosols can irritate the airway and may cause airway narrowing, especially in patients with asthma, COPD, emphysema, or other reactive airway conditions.

One proposed mechanism involves airway mast cells. Exposure to hypertonic aerosols may cause mast cells to release mediators such as histamine. These mediators can lead to bronchoconstriction, wheezing, chest tightness, and shortness of breath. This same airway irritation that helps stimulate cough can also create risk in sensitive patients.

Because of this, patients should be monitored before, during, and after treatment. The therapist should assess breath sounds, respiratory rate, breathing pattern, work of breathing, and patient comfort. In patients with reactive airways, pulmonary function may be monitored using FEV₁.

Some protocols recommend pretreatment with a fast-acting beta agonist such as albuterol before hypertonic saline. This helps reduce the risk of bronchospasm and may improve airway caliber before the patient inhales the hypertonic aerosol.

Note: If bronchospasm occurs, the treatment should be stopped. A beta agonist bronchodilator may be given to reverse bronchoconstriction. Future induction attempts may require a lower concentration, normal saline, hypotonic saline, or a different diagnostic approach.

Monitoring During Therapy

Monitoring is important because the patient’s response can change during treatment. The therapist should watch for wheezing, increased dyspnea, chest tightness, coughing that becomes excessive, a drop in oxygen saturation, or signs of respiratory distress.

In patients with reactive airway disease, FEV₁ may be measured after bronchodilator pretreatment to establish a baseline. During induction, the procedure may be stopped if FEV₁ falls by 20% or more from the post-bronchodilator baseline. This helps prevent a mild reaction from progressing to a more serious episode of bronchospasm.

The therapist should also evaluate whether the procedure is achieving its goal. In sputum induction, the goal is not simply to deliver the full treatment time. The goal is to collect an adequate lower-airway specimen. If the patient produces a good sample early, the procedure may not need to continue.

For long-term secretion therapy, monitoring should include pulmonary function, symptom trends, frequency of respiratory infections, need for antibiotics, emergency visits, hospitalizations, and tolerance of therapy. This is especially relevant in conditions such as cystic fibrosis, where hypertonic saline may be used regularly.

Hypertonic Saline in Cystic Fibrosis

Cystic fibrosis is one of the most important clinical conditions associated with inhaled hypertonic saline. Patients with cystic fibrosis often have thick, tenacious secretions that are difficult to clear. These secretions contribute to airway obstruction, infection, inflammation, and progressive lung damage.

Hypertonic saline can help by improving airway hydration and mucociliary clearance. Nebulized 7% hypertonic saline is commonly discussed in cystic fibrosis care. It is thought to draw water into the airway surface liquid, making secretions easier to mobilize and clear.

In cystic fibrosis, hypertonic saline is often used as part of a larger airway clearance regimen. A common sequence may include an inhaled bronchodilator first, followed by a mucoactive therapy such as dornase alfa, hypertonic saline, or N-acetylcysteine, followed by airway clearance therapy and directed coughing. If inhaled antibiotics are prescribed, they may be given after airway clearance depending on the treatment plan.

The bronchodilator is usually given first to reduce airway narrowing and improve aerosol delivery. This is especially important because hypertonic saline can provoke bronchospasm. Airway clearance therapy then helps remove the loosened secretions.

Studies have shown that long-term inhaled hypertonic saline can improve pulmonary function in patients with cystic fibrosis. It may also reduce exacerbations in some patients. Because it is relatively inexpensive and useful for secretion clearance, it is often recommended as part of the treatment regimen for appropriate patients.

Hypertonic Saline in Bronchiectasis

Bronchiectasis is another condition in which hypertonic saline may be considered. Bronchiectasis involves abnormal widening of the airways, chronic infection, inflammation, and impaired mucus clearance. Patients often have chronic cough and sputum production.

Management usually focuses on antibiotics when infection is present, airway clearance techniques, cough maneuvers, exercise, hydration, and bronchopulmonary hygiene. Inhaled hyperosmolar agents such as hypertonic saline or mannitol may help some patients clear secretions more effectively.

The evidence for hypertonic saline in bronchiectasis appears less definitive than in cystic fibrosis. It may be helpful for selected patients, especially those with thick secretions and difficulty expectorating mucus. However, tolerance must be considered because bronchiectasis patients may also have airway reactivity.

As with cystic fibrosis, hypertonic saline should not be viewed as a stand-alone treatment. It is usually part of a broader secretion management plan that may include bronchodilators, airway clearance devices, chest physiotherapy, postural drainage, directed coughing, and treatment of infection.

Hypertonic Saline and Airway Clearance

In airway clearance therapy, hypertonic saline is best understood as a secretion-mobilizing therapy. It helps make secretions easier to cough out by increasing airway surface liquid and stimulating cough. It is not used to treat bronchospasm directly and should not be confused with bronchodilator therapy.

Patients with retained secretions, thick mucus, or ineffective cough may benefit from therapies that improve secretion clearance. Hypertonic saline may be considered when secretions are difficult to mobilize, especially in cystic fibrosis or bronchiectasis.

The timing of hypertonic saline matters. If the patient also uses bronchodilators, the bronchodilator is commonly administered first. This helps open the airways and reduce the risk of bronchospasm. After hypertonic saline, airway clearance techniques can help move secretions from the peripheral airways toward the larger airways, where the patient can cough them out.

Airway clearance methods may include directed coughing, huff coughing, positive expiratory pressure devices, oscillatory PEP devices, chest physiotherapy, postural drainage, high-frequency chest wall oscillation, and exercise. Hypertonic saline can support these methods by helping mobilize secretions before or during clearance.

Hypertonic Saline Compared With Other Secretion Therapies

Hypertonic saline is one of several therapies used to manage secretions. It is important to understand how it differs from other agents.

• Normal saline is isotonic and less irritating. It may be used when hypertonic saline is not tolerated, but it usually has a weaker osmotic effect. Hypotonic saline has a lower salt concentration and may also be substituted in some cases if hypertonic saline causes too much irritation.
• Dornase alfa is different because it is an enzymatic mucolytic. It breaks down extracellular DNA in infected secretions, which helps reduce mucus viscosity in cystic fibrosis. Dornase alfa has a specific role in CF and should not be confused with saline therapy.
• N-acetylcysteine is another mucoactive agent. It can reduce mucus viscosity by breaking disulfide bonds in mucoproteins, although it can also cause airway irritation and bronchospasm. It has a different mechanism than hypertonic saline.
• Mannitol is a hyperosmolar agent that may also help draw water into airway secretions. Like hypertonic saline, it is used to improve mucus clearance in selected patients.
• Atropine and other drying agents are generally not helpful for thick retained secretions because they can dry airway mucus and make it harder to clear. This is an important exam concept: therapies that dry secretions can worsen mucus plugging in patients who already have tenacious secretions.

Hypertonic Saline in Bronchial Challenge Testing

Because hypertonic saline can trigger bronchospasm in sensitive airways, it may also be used in bronchial challenge testing. A bronchial challenge test evaluates airway hyperresponsiveness by exposing the airways to a stimulus and measuring the response.

In this context, the bronchospasm caused by hypertonic saline is not an unwanted side effect but part of the test response. Patients with hyperreactive airways may demonstrate a measurable drop in lung function after inhaling the stimulus.

This use is different from sputum induction or secretion clearance. In sputum induction, bronchospasm is a risk to prevent and monitor. In bronchial challenge testing, airway response is the purpose of the test, but the procedure must still be performed carefully with appropriate monitoring and rescue medication available.

IV Hypertonic Saline

Although this article focuses mainly on aerosolized hypertonic saline in respiratory care, it is helpful to recognize that hypertonic saline also has nonrespiratory uses. Intravenous hypertonic saline may be used as osmotherapy in certain patients with elevated intracranial pressure, such as traumatic brain injury.

This use is completely different from inhaled hypertonic saline. IV hypertonic saline works through systemic osmotic effects to help draw water out of swollen brain tissue and reduce intracranial pressure. Aerosolized hypertonic saline is used in respiratory care to induce sputum and mobilize airway secretions.

For exam purposes, the route matters. Aerosolized hypertonic saline is associated with sputum induction, secretion clearance, cystic fibrosis, bronchiectasis, and bronchospasm risk. IV hypertonic saline is associated with osmotherapy for elevated intracranial pressure in selected critical care situations.

Adverse Effects and Contraindications

The most important adverse effect of inhaled hypertonic saline is bronchospasm. Patients may develop wheezing, chest tightness, shortness of breath, increased work of breathing, or a measurable decline in FEV₁. This is most likely in patients with asthma, COPD, emphysema, or other hyperreactive airway disorders.

Coughing is expected, especially during sputum induction. However, excessive coughing may cause discomfort, fatigue, lightheadedness, nausea, or distress. The therapist should distinguish between a productive cough that helps obtain a specimen and a worsening reaction that requires stopping the procedure.

Some patients may experience throat irritation, salty taste, chest discomfort, or temporary oxygen desaturation. If the patient becomes unstable or cannot tolerate the treatment, therapy should be discontinued.

Note: Hypertonic saline should be used cautiously in patients who have severe airway reactivity or a history of poor tolerance. Pretreatment with a bronchodilator may be needed. In some cases, a lower saline concentration or an alternative method may be safer.

Patient Education

Patients should understand why hypertonic saline is being used. For sputum induction, the therapist should explain that the purpose is to help the patient cough mucus from the lungs into a sterile cup. The patient should be told not to provide saliva alone because saliva may not be useful for diagnosis.

For long-term therapy, such as in cystic fibrosis, patients should be taught how to use the nebulizer correctly. This includes assembling the equipment, adding the correct dose, breathing through the device properly, and cleaning and drying the equipment after use.

Cleaning is especially important because contaminated nebulizer equipment can expose the patient to microorganisms. Patients should follow the cleaning instructions provided by the healthcare team and device manufacturer.

Patients should also be taught to recognize adverse reactions. They should report wheezing, chest tightness, shortness of breath, or unusual discomfort during or after treatment. If a bronchodilator is prescribed before hypertonic saline, they should understand the correct order of treatments.

Key Takeaways

For respiratory therapy students, hypertonic saline is a high-yield topic because it connects basic physiology, aerosol therapy, pharmacology, sputum collection, and airway clearance.

• Hypertonic saline has a concentration greater than 0.9% sodium chloride. Common aerosolized concentrations include 3% to 10%, with 7% commonly discussed in cystic fibrosis and sputum induction.
• Hypertonic saline works mainly by osmotic action. It draws water into the airway surface liquid, increases secretion volume, stimulates cough, and helps mobilize mucus.
• It is commonly used for sputum induction when a patient cannot produce a sample spontaneously. It may be used for suspected tuberculosis, fungal infection, Pneumocystis jirovecii pneumonia, or lung cancer cytology. It should not be used for routine bacterial culture because the high salt concentration can inhibit bacterial growth.
• Bronchospasm is the major risk. Patients with asthma, COPD, or reactive airways need careful monitoring. Pretreatment with albuterol may be used, and treatment should be stopped if bronchospasm or significant respiratory distress occurs.
• Hypertonic saline is useful in cystic fibrosis because it helps improve secretion clearance. It may also help some patients with bronchiectasis, although the evidence is less definitive than in cystic fibrosis.

Hypertonic Saline Practice Questions

1. What is hypertonic saline?
Hypertonic saline is a sodium chloride solution with a concentration greater than 0.9%, giving it a higher osmotic pressure than normal saline.

2. What is considered normal saline?
Normal saline is 0.9% sodium chloride and is considered approximately isotonic with body fluids.

3. Why is hypertonic saline called hypertonic?
It is called hypertonic because it has a higher osmotic pressure than isotonic body fluids.

4. What does hypertonic saline do to water movement?
Hypertonic saline draws water toward the area with the higher salt concentration.

5. How does aerosolized hypertonic saline affect airway secretions?
It pulls water into the airway surface liquid, increasing secretion volume and helping mobilize mucus.

6. What is the main purpose of hypertonic saline in sputum induction?
The main purpose is to stimulate coughing and help the patient produce a usable lower-airway sputum specimen.

7. What concentrations of hypertonic saline are commonly used for sputum induction?
Common concentrations include 3% to 10%, although some sources mention 1.8% to 10%.

8. What concentration is commonly used in cystic fibrosis therapy?
Nebulized 7% hypertonic saline is commonly used in cystic fibrosis therapy.

9. Is hypertonic saline a bronchodilator?
No. Hypertonic saline is not a bronchodilator because it does not directly relax airway smooth muscle.

10. Is hypertonic saline considered a steroid or antibiotic?
No. Hypertonic saline is not a steroid or antibiotic and does not directly reduce inflammation or kill microorganisms.

11. What category of aerosol therapy includes hypertonic saline?
Hypertonic saline is included under bland aerosol therapy because it is a saline aerosol without direct pharmacologic action.

12. Why is hypertonic saline considered mucoactive?
It is considered mucoactive because it helps improve secretion clearance and promotes sputum expectoration.

13. Why is hypertonic saline better described as an expectorant than a true mucolytic?
It helps remove secretions by increasing watery mucus and stimulating cough rather than chemically breaking down mucus.

14. What is sputum induction?
Sputum induction is a procedure used to help a patient produce a sputum sample when they cannot do so spontaneously.

15. What type of specimen is needed during sputum induction?
A true lower-airway sputum specimen is needed, not saliva from the mouth.

16. Why is saliva not acceptable as a sputum specimen?
Saliva does not represent lower-airway secretions and may not provide useful diagnostic information.

17. What conditions may require sputum induction with hypertonic saline?
It may be used when tuberculosis, fungal infection, Pneumocystis jirovecii pneumonia, or lung cancer is suspected.

18. Why should hypertonic saline not be used for routine bacterial culture collection?
The high salt concentration can inhibit the growth of many bacteria and interfere with culture results.

19. What equipment is often used to deliver hypertonic saline for sputum induction?
An ultrasonic nebulizer is often used because it can produce a dense aerosol.

20. Can a jet nebulizer be used for hypertonic saline sputum induction?
Yes. A jet nebulizer may be used if it can deliver aerosol continuously for the required treatment period.

21. Why is an ultrasonic nebulizer often preferred for sputum induction?
It is often preferred because it can generate a high-density mist that helps stimulate sputum production.

22. How long does sputum induction with hypertonic saline typically last?
The procedure often lasts about 5 to 20 minutes, depending on the protocol.

23. What should the patient do before sputum induction to reduce contamination?
The patient may rinse and gargle with water, and some protocols include brushing the teeth and cleaning the tongue.

24. Why may sputum induction for suspected tuberculosis be done early in the morning?
Early morning collection may improve the chance of obtaining a useful lower-airway specimen.

25. What infection control precautions are important when tuberculosis is suspected?
The procedure should be performed with airborne precautions, often in a negative-pressure room or booth with proper respiratory protection.

26. What is the major safety concern with aerosolized hypertonic saline?
The major safety concern is bronchospasm, especially in patients with asthma, COPD, or other reactive airway conditions.

27. Why can hypertonic saline cause bronchospasm?
It can irritate the airway and may trigger mediator release, such as histamine, leading to airway narrowing.

28. Which patients need extra caution when receiving hypertonic saline?
Patients with asthma, emphysema, COPD, or hyperreactive airways need extra caution and monitoring.

29. What medication may be given before hypertonic saline to reduce bronchospasm risk?
A fast-acting beta agonist, such as albuterol, may be given before treatment.

30. What should be done if bronchospasm occurs during hypertonic saline therapy?
The treatment should be stopped, and a beta-agonist bronchodilator may be given if needed.

31. What breath sound may indicate bronchospasm during treatment?
Wheezing may indicate bronchospasm during hypertonic saline therapy.

32. What symptoms may suggest the patient is not tolerating hypertonic saline?
Chest tightness, increased shortness of breath, wheezing, distress, nausea, or lightheadedness may indicate poor tolerance.

33. What pulmonary function value may be monitored during sputum induction in reactive airway patients?
FEV₁ may be monitored to assess for airway narrowing during the procedure.

34. When should sputum induction be stopped based on FEV₁?
It should be stopped if FEV₁ falls by 20% or more from the post-bronchodilator baseline.

35. Why is a post-bronchodilator FEV₁ baseline useful?
It provides a comparison point to detect significant bronchoconstriction during sputum induction.

36. What is the goal of monitoring breath sounds during hypertonic saline therapy?
The goal is to detect bronchospasm, worsening airflow obstruction, or other adverse responses.

37. What does hypertonic saline stimulate besides mucus hydration?
It stimulates reflex coughing, which helps move secretions out of the airways.

38. How does hypertonic saline affect the sol-gel layer of the respiratory tract?
It draws water into the sol-gel layer, increasing airway surface liquid and secretion volume.

39. Why does hypertonic saline help produce a more watery sputum sample?
Its osmotic effect increases water movement into airway secretions, making them more fluid.

40. What determines the amount of sputum produced during hypertonic saline therapy?
The amount of sputum may depend partly on the osmolarity of the inhaled aerosol and patient response.

41. What is the purpose of using a sterile collection cup during sputum induction?
A sterile collection cup helps preserve the specimen for accurate laboratory analysis.

42. What specimen feature suggests the sample came from the lower airway?
Visible mucus plugs or mucus strands suggest the specimen came from the lower airway.

43. What specimen amount is often considered adequate for sputum analysis?
An adequate specimen is often about 2 to 5 mL, depending on the test being performed.

44. How much sputum may be needed for reliable acid-fast bacilli analysis?
About 4 to 5 mL may be needed for reliable acid-fast bacilli analysis.

45. What should the respiratory therapist encourage during sputum induction?
The respiratory therapist should encourage coughing and expectoration into the specimen container.

46. What should be avoided when collecting a sputum specimen?
The patient should avoid submitting saliva instead of true sputum from the lower airways.

47. Why might sputum induction need to be repeated over several days?
Repeating the procedure may increase the chance of collecting a good diagnostic specimen.

48. What makes sputum induction useful compared with bronchoscopy?
It is simple, noninvasive, relatively safe, and may prevent the need for bronchoscopy if successful.

49. What type of room may be needed for sputum induction when infection is suspected?
A negative-pressure room or booth may be needed to reduce the risk of airborne exposure.

50. Why is a HEPA filter useful during sputum induction?
A HEPA filter helps reduce environmental contamination from aerosolized organisms during the procedure.

51. How is hypertonic saline used in cystic fibrosis?
It is used to improve airway hydration, mobilize thick secretions, and support mucociliary clearance.

52. Why are cystic fibrosis patients often treated with hypertonic saline?
They often have thick, tenacious secretions that are difficult to clear from the airways.

53. What is the expected benefit of long-term inhaled hypertonic saline in cystic fibrosis?
It may improve pulmonary function and reduce respiratory exacerbations in appropriate patients.

54. How often is nebulized 7% hypertonic saline commonly recommended for eligible cystic fibrosis patients?
It is commonly recommended twice daily for patients 6 years and older, depending on the treatment plan.

55. Why is a bronchodilator often given before hypertonic saline in cystic fibrosis?
A bronchodilator helps reduce bronchospasm risk and may improve airway caliber before secretion mobilization.

56. What treatment often follows hypertonic saline in a cystic fibrosis airway clearance regimen?
Airway clearance therapy, such as directed coughing or chest physiotherapy, often follows hypertonic saline.

57. What medication may be used with hypertonic saline to manage cystic fibrosis secretions?
Dornase alfa may be used because it helps reduce mucus viscosity by breaking down DNA in secretions.

58. How does dornase alfa differ from hypertonic saline?
Dornase alfa enzymatically breaks down DNA in mucus, while hypertonic saline mainly draws water into airway secretions.

59. What inhaled antibiotics may be used in cystic fibrosis management?
Tobramycin, colistin, or aztreonam may be used when indicated, especially with Pseudomonas infection.

60. Where does hypertonic saline fit in a cystic fibrosis treatment sequence?
It is commonly given after a bronchodilator and before airway clearance therapy.

61. What should be the first priority for a cystic fibrosis patient in acute respiratory distress?
Supplemental oxygen should be provided to maintain adequate oxygen saturation.

62. What oxygen saturation goal is commonly mentioned for cystic fibrosis patients in acute distress?
The goal is often to maintain SpO₂ above 90%.

63. Why is atropine not appropriate for cystic fibrosis patients with thick secretions?
Atropine can dry secretions and make thick mucus harder to clear.

64. What airway clearance device may be used with hypertonic saline in cystic fibrosis?
A Flutter valve may be used to help mobilize and clear secretions.

65. What is the main goal of combining hypertonic saline with airway clearance techniques?
The goal is to loosen secretions and then physically move them out of the airways.

66. How may hypertonic saline help patients with bronchiectasis?
It may help clear retained secretions by increasing airway surface liquid and promoting cough.

67. Is the evidence for hypertonic saline stronger in cystic fibrosis or bronchiectasis?
The evidence is stronger in cystic fibrosis than in bronchiectasis.

68. What is bronchiectasis associated with?
Bronchiectasis is associated with abnormal airway widening, chronic infection, inflammation, and impaired mucus clearance.

69. What are common airway clearance methods used in bronchiectasis?
Chest physiotherapy, postural drainage, cough maneuvers, humidification, and high-frequency chest wall oscillation may be used.

70. What other hyperosmolar agent may be used for secretion clearance besides hypertonic saline?
Mannitol may also be used as a hyperosmolar secretion-clearance agent.

71. What is the main role of hypertonic saline in bronchiectasis management?
Its main role is to help mobilize secretions as part of a broader bronchopulmonary hygiene plan.

72. Why should hypertonic saline not be considered a stand-alone treatment for bronchiectasis?
Bronchiectasis often requires a broader plan that may include antibiotics, airway clearance, cough techniques, and secretion management.

73. What is bronchopulmonary hygiene?
Bronchopulmonary hygiene refers to therapies that help clear secretions and maintain airway patency.

74. Why may patients with bronchiectasis need careful monitoring during hypertonic saline therapy?
They may have airway reactivity and can develop bronchospasm or poor tolerance during treatment.

75. What is the primary purpose of using hypertonic saline with retained secretions?
The primary purpose is to facilitate secretion mobilization and improve the patient’s ability to expectorate mucus.

76. What is the difference between aerosolized and IV hypertonic saline?
Aerosolized hypertonic saline is used for sputum induction and secretion clearance, while IV hypertonic saline may be used as osmotherapy for elevated intracranial pressure.

77. What is the purpose of IV hypertonic saline in traumatic brain injury?
IV hypertonic saline may help decrease intracranial pressure by drawing fluid away from swollen brain tissue.

78. Why is route of administration important when discussing hypertonic saline?
The route matters because inhaled hypertonic saline affects airway secretions, while IV hypertonic saline has systemic osmotic effects.

79. What does it mean that hypertonic saline has no direct pharmacologic action on the lungs?
It means hypertonic saline does not directly act like a bronchodilator, steroid, antibiotic, or anti-inflammatory drug.

80. How can hypertonic saline stimulate watery secretions?
It may trigger a vagal nerve-mediated reflex that causes bronchial and submucosal glands to release more watery secretions.

81. What is the main reason hypertonic saline can help with productive coughing?
It increases airway fluid and secretion volume, making mucus easier to cough out.

82. Why are bland aerosols not considered true mucolytics?
They do not chemically break down mucus structure, even though they may help improve secretion clearance.

83. What is the difference between a mucolytic and an expectorant?
A mucolytic breaks down mucus, while an expectorant helps the patient remove secretions through coughing or increased secretion clearance.

84. Why does hypertonic saline have a stronger irritating effect than normal saline?
It is farther from isotonic than normal saline, making it more irritating to airway tissues.

85. What is the relationship between airway irritation and sputum induction?
Airway irritation helps stimulate cough, which can help the patient produce a sputum specimen.

86. What should clinicians assess before giving hypertonic saline?
Clinicians should assess the indication, airway reactivity, breath sounds, breathing pattern, respiratory rate, and patient tolerance.

87. What should be monitored during long-term hypertonic saline therapy?
Infection frequency, antibiotic use, emergency visits, hospitalizations, pulmonary function, and tolerance should be monitored.

88. Why is nebulizer cleaning important for patients using hypertonic saline?
Proper cleaning reduces the risk of contamination and infection from reused aerosol equipment.

89. What should patients be taught about the order of cystic fibrosis treatments?
They should understand that a bronchodilator is often used before hypertonic saline, followed by airway clearance therapy.

90. What should the patient report during or after hypertonic saline therapy?
The patient should report wheezing, chest tightness, shortness of breath, unusual discomfort, or worsening respiratory symptoms.

91. What is Hyper-Sal 7%?
Hyper-Sal 7% is an example of a commercially available hypertonic saline solution used for inhalation therapy.

92. What adult dose range is commonly listed for inhaled saline solutions?
An adult dose may be 3 to 5 mL by small-volume nebulizer or ultrasonic nebulizer, as ordered.

93. Why may hypertonic saline particles enlarge during inhalation?
They may absorb water vapor, which can increase particle size and make upper-airway impaction more likely.

94. What is upper-airway impaction?
Upper-airway impaction occurs when aerosol particles deposit in the upper airway instead of reaching deeper lung regions.

95. Why is patient coaching important during sputum induction?
Coaching helps the patient cough deeply and produce true sputum rather than saliva.

96. What should be done if hypertonic saline is too irritating for sputum induction?
Normal saline or hypotonic saline may be substituted if hypertonic saline is not tolerated.

97. Why should distilled water not be used for induced sputum procedures?
Distilled water is not recommended because it can be excessively irritating and is not the appropriate solution for sputum induction.

98. How does hypertonic saline support mucociliary clearance?
It hydrates the airway surface liquid, which can help cilia move mucus more effectively.

99. What is the main board exam takeaway about hypertonic saline and bacterial cultures?
Hypertonic saline should not be used for routine bacterial cultures because it can inhibit bacterial growth.

100. What is the overall respiratory care purpose of hypertonic saline?
The overall purpose is to draw water into airway secretions, stimulate cough, mobilize mucus, and help obtain sputum when needed.

Final Thoughts

Hypertonic saline is a useful respiratory therapy tool because it applies a simple osmotic principle to a common clinical problem: retained or difficult-to-produce secretions. When inhaled as an aerosol, it draws water into the airway surface liquid, increases secretion volume, stimulates cough, and helps patients clear mucus or produce a diagnostic sputum sample.

Its strongest respiratory uses include sputum induction and airway clearance in cystic fibrosis, with possible benefit in bronchiectasis. However, it can irritate the airways and cause bronchospasm, especially in reactive airway disease, so careful assessment, monitoring, and appropriate bronchodilator use are essential.